EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Beyond Opioids: A Review of Suzetrigine for Acute Pain Management

Andrew Pham, Hua Yep, Sebastian Wozniak, Anisha Javvaji, Eman Nada iD, Sergio Bergese iD

International Journal of Molecular Sciences · 10.10.2025 · 26 (20) · 9865

DOI: 10.3390/ijms26209865 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 10.10.2025. Verfasst von Andrew Pham und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, Stony Brook Hospital, Stony Brook, NY 11794, USA. Hauptthemen laut MEDLINE: Acute Pain, Analgesics, Opioid, Pain Management. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The ongoing opioid epidemic in the United States highlights the need for novel analgesics with reduced risk of misuse, dependence, and adverse central nervous system effects. Suzetrigine (trade name Journavx), a first-in-class selective Nav1.8 (a sodium channel expressed in peripheral nociceptors) inhibitor, was approved by the FDA in early 2025 and marketed as the first non-opioid analgesic in over two decades. Current studies have shown that suzetrigine has potential in treating acute pain perioperatively for minimally to moderately painful ambulatory procedures. However, suzetrigine appears less potent than hydrocodone-acetaminophen in this context, and it remains unclear how effective suzetrigine is in treating more severe postoperative pain. Notably, all current studies are limited to short durations of treatment; further studies will be required to delineate suzetrigine’s long-term efficacy, safety, and addiction potential to be utilized in the management of chronic pain patients. This article provides a review of the current literature available on the use of suzetrigine in treating acute pain.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Acute PainAnalgesics, OpioidPain ManagementHumansAnimals

Stichwörter der Autor:innen

Nav1.8acute painnonopioidsodium channelsuzetrigine

Substanzen

Analgesics, Opioid

Autor:innen und Institutionen

  • Department of Anesthesiology, Stony Brook Hospital, Stony Brook, NY 11794, USA.
  • Renaissance School of Medicine, Stony Brook, NY 11794, USA.

ORCID-Profile: Eman Nada, Sergio Bergese

Zitieren

APA

Pham, A., Yep, H., Wozniak, S., Javvaji, A., Nada, E., & Bergese, S. (2025). Beyond Opioids: A Review of Suzetrigine for Acute Pain Management. International Journal of Molecular Sciences, 26(20), 9865. https://doi.org/10.3390/ijms26209865

Vancouver

Pham A, Yep H, Wozniak S, Javvaji A, Nada E, Bergese S. Beyond Opioids: A Review of Suzetrigine for Acute Pain Management. International Journal of Molecular Sciences. 2025;26(20):9865. doi:10.3390/ijms26209865

BibTeX
@article{Pham2025,
  author = {Pham, Andrew and Yep, Hua and Wozniak, Sebastian and Javvaji, Anisha and Nada, Eman and Bergese, Sergio},
  title = {Beyond Opioids: A Review of Suzetrigine for Acute Pain Management},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  volume = {26},
  number = {20},
  pages = {9865},
  doi = {10.3390/ijms26209865}
}
Kostenlos starten →